BUDFF
Anheuser-Busch InBev SA/NV
$81.95
-1.00%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 14, 2026
SEC
AB InBev filed its coordinated articles of association as amended on April 29, 2026, via a 6-K. The filing is a routine
6-K — Impact 2/10
May 5, 2026
SEC
AB InBev reported strong Q1 2026 results with revenue of $15.3B (+12% YoY), profit from operations of $4.1B (+16.7%), an
6-K — Impact 7/10
Mar 27, 2026
SEC
Anheuser-Busch InBev announced the retirement of its long-serving Chairman Martin J. Barrington, effective after the Ann
6-K — Impact 3/10
Analyst Ratings
9Strong Buy
18Buy
5Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.0/10.
NEUTRAL
6-K
2/10
AB InBev filed its coordinated articles of association as amended on April 29, 2026, via a 6-K. The
May 14, 2026
BULLISH
6-K
7/10
AB InBev reported strong Q1 2026 results with revenue of $15.3B (+12% YoY), profit from operations o
May 5, 2026
NEUTRAL
6-K
3/10
Anheuser-Busch InBev announced the retirement of its long-serving Chairman Martin J. Barrington, eff
Mar 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 84% buy across 32 analysts — 9 strong buy, 18 buy, 5 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $16.4B | 9.2% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $16.3B | 7.7% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $64.4B | 8.5% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $66.8B | 3.8% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 9 | 18 | 5 | 0 | 0 | 84% | |
| May 1, 2026 | 9 | 18 | 6 | 0 | 0 | 82% | |
| Apr 1, 2026 | 8 | 18 | 7 | 0 | 0 | 79% | |
| Mar 1, 2026 | 9 | 18 | 6 | 0 | 0 | 82% | |
| Feb 1, 2026 | 9 | 19 | 4 | 0 | 0 | 88% | |
| Jan 1, 2026 | 9 | 18 | 4 | 0 | 0 | 87% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.